Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 33 entries
No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
CA5B
💬1. CA5B
| [2] Nitrogen metabolism Nitrogen metabolism, Metabolic pathways | Acetazolamide
Acetazolamide
💬1. CA5B
| Acetazolamide | [8] 13 13, 86, 90, 115, 154, 155, 225, 230 💬1. CA5B
| ||||||||||||||||||||||||||||||||||||||||||||||||
2 |
F8
💬2. F8
| [1] Complement and coagulation cascades Complement and coagulation cascades | Desmopressin
Desmopressin
💬2. F8
| Desmopressin | [6] 6 6, 64, 72, 75, 225, 288 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||
3 |
CA14
💬3. CA14
| [2] Nitrogen metabolism Nitrogen metabolism, Metabolic pathways | Acetazolamide
Acetazolamide
💬3. CA14
| Acetazolamide | [8] 13 13, 86, 90, 115, 154, 155, 225, 230 💬3. CA14
| ||||||||||||||||||||||||||||||||||||||||||||||||
4 |
GUCY1A2
💬4. GUCY1A2
| [11] Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, Vascular smooth muscle contraction, Gap junction, Platelet activation, Circadian entrainment, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion [11] Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, Vascular smooth muscle contr ... | Riociguat
Riociguat
💬4. GUCY1A2
| Riociguat | [6] 51 51, 84, 86, 88, 225, 299 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||
5 |
GUCY1A1
💬5. GUCY1A1
| [11] Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, Vascular smooth muscle contraction, Gap junction, Platelet activation, Circadian entrainment, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion [11] Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, Vascular smooth muscle contr ... | Riociguat
Riociguat
💬5. GUCY1A1
| Riociguat | [6] 51 51, 84, 86, 88, 225, 299 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||
6 |
GUCY1B1
💬6. GUCY1B1
| [11] Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, Vascular smooth muscle contraction, Gap junction, Platelet activation, Circadian entrainment, Long-term depression, Oxytocin signaling pathway, Renin secretion, Salivary secretion [11] Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway, Vascular smooth muscle contr ... | Riociguat
Riociguat
💬6. GUCY1B1
| Riociguat | [6] 51 51, 84, 86, 88, 225, 299 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||
7 |
HMGCR
💬7. HMGCR
| [4] Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, AMPK signaling pathway, Bile secretion | Atorvastatin
Atorvastatin
💬7. HMGCR
| Atorvastatin | [19] 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬7. HMGCR
| ||||||||||||||||||||||||||||||||||||||||||||||||
8 |
CA13
💬8. CA13
| [2] Nitrogen metabolism Nitrogen metabolism, Metabolic pathways | Acetazolamide
Acetazolamide
💬8. CA13
| Acetazolamide | [8] 13 13, 86, 90, 115, 154, 155, 225, 230 💬8. CA13
| ||||||||||||||||||||||||||||||||||||||||||||||||
9 |
NR3C2
💬9. NR3C2
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption | Spironolactone
Spironolactone
💬9. NR3C2
| Spironolactone | [8] 46 46, 58, 67, 86, 113, 210, 218, 225 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||
10 |
ATP4A
💬10. ATP4A
| [4] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Collecting duct acid secretion, Gastric acid secretion [4] Oxidative phosphorylation, Metabolic pathways, Collecting duct acid secretion, Gastric acid secr ... | Omeprazole
Omeprazole
💬10. ATP4A
| Omeprazole | [14] 6 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299 💬10. ATP4A
|